Related Experiment Video
Updated: Sep 28, 2025

06:55
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
Published on: May 11, 2014
12.1K
Artificial intelligence-assisted staging in Barrett's carcinoma.
Mate Knabe1, Lukas Welsch1, Tobias Blasberg2
1Department of Gastroenterology, Frankfurt University Hospital, Frankfurt, Germany.
Endoscopy
|March 30, 2022
Summary
An artificial intelligence (AI) system accurately staged Barrett's carcinoma using endoscopic images, showing potential to aid in clinical decisions. This AI tool achieved 73% overall accuracy in identifying esophageal cancer stages.
Area of Science:
- Gastroenterology
- Oncology
- Medical Imaging
- Artificial Intelligence
Background:
- The T stage of Barrett's carcinoma is critical for treatment decisions, but current preoperative staging methods like endoscopic ultrasound have limitations.
- Novel tools are needed to improve the accuracy of staging Barrett's carcinoma.
- Artificial intelligence (AI) shows promise in interpreting endoscopic images for neoplasia detection.
Purpose of the Study:
- To investigate the accuracy of an AI system in determining the T stage of Barrett's carcinoma based on endoscopic images.
- To evaluate the AI system's performance in differentiating between various stages of esophageal cancer.
Main Methods:
- A convolutional neural network was trained and validated using 1020 endoscopic images from 577 patients with Barrett's adenocarcinoma.
- The dataset comprised 821 training images and 199 validation images.
- The AI model's performance was assessed based on sensitivity, specificity, and accuracy for different cancer stages.
Main Results:
- The AI system achieved 85% accuracy in recognizing Barrett's mucosa without neoplasia.
- For mucosal cancer, the AI demonstrated a sensitivity of 72% and accuracy of 68%.
- The AI system achieved 67% accuracy for early neoplasia (
Conclusions:
- The AI system demonstrated high accuracy in identifying esophageal cancer stages from endoscopic images.
- The findings suggest that AI can serve as a valuable tool to assist endoscopists in clinical decision-making for Barrett's carcinoma.
- Further research and validation are warranted to integrate AI into routine clinical practice for improved patient outcomes.
Related Concept Videos
Barrett Esophagus-I: Introduction
247
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
247
Barrett Esophagus-II: Clinical Manifestations and Management
331
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
331

